Drug Type Small molecule drug |
Synonyms Alprostadil alfadex (JP17), PGE1・CD, PGE1・α-CD + [5] |
Target |
Mechanism EP1 agonists(Prostanoid EP1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (27 Aug 1979), |
Regulation- |
Molecular FormulaC56H94O35 |
InChIKeyLYRPNNXUPAXZGU-OJQZDGIKSA-N |
CAS Registry55648-20-9 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Erectile Dysfunction | JP | 23 Feb 2011 | |
Rest pain | JP | 29 May 1987 | |
Intraoperative hypertension | JP | 31 Mar 1987 | |
Peripheral Vascular Diseases | JP | 27 Aug 1979 | |
Pressure Ulcer | JP | 27 Aug 1979 | |
Thromboangiitis Obliterans | JP | 27 Aug 1979 | |
Ulcer | JP | 27 Aug 1979 |
Not Applicable | Scleroderma, Systemic urokinase plasminogen activator | urokinase plasminogen activator receptor | plasminogen activator inhibitor I ... View more | 40 | Intravenous alprostadil-alphacyclodestrine | gaosvnkzej(bmkazlhmms) = tumjnkajoa fifmvfeqbz (wwwibqgtex ) View more | - | 18 Jun 2003 | |
INTRAVENOUS ALPROSTADIL-ALPHACYCLODESTRINE | gaosvnkzej(bmkazlhmms) = dgotjfukxn fifmvfeqbz (wwwibqgtex ) View more | ||||||
Not Applicable | Scleroderma, Systemic MCP1 | RANTES | - | Alprostadil alpha-cyclodextrin | sjgajfiryc(ggncdobgxe) = mcifzzgzeg ujtjarpfju (ylgecodzmu ) View more | - | 18 Jun 2003 | |
Alprostadil alpha-cyclodextrin | sjgajfiryc(ggncdobgxe) = jmzoylekkh ujtjarpfju (ylgecodzmu ) View more |